Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alpha-flupenthixol
2. Cis-flupenthixol
3. Emergil
4. Fluanxol
5. Flupenthixol
6. Flupentixol
1. 51529-01-2
2. Flupenthixol Dihydrochloride
3. Emergil
4. Cis-(z)-flupenthixol Dihydrochloride
5. 2413-38-9
6. Flupentixol Hcl
7. Cis-(z)-flupentixol Dihydrochloride
8. Fupentixol Dihydrochloride
9. (z)-flupenthixol Dihydrochloride
10. Flupenthixol 2hcl
11. (e/z)-flupentixol Dihydrochloride
12. Flupenthixol, Dihydrochloride
13. Fx 703
14. Flupentixol Dihydrochloride Cis-(z)
15. 96l0z069n1
16. Cis-(z)-flupentixol (dihydrochloride)
17. Flupentixol Hydrochloride
18. (z)-4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Dihydrochloride
19. 2-[4-[(3z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol;dihydrochloride
20. N 7009
21. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride, (z)-
22. (z)-4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride
23. Einecs 219-321-4
24. Nsc 170952
25. Unii-96l0z069n1
26. Prestwick_902
27. Cis-flupenthixol 2hcl
28. Unii-hat84mlq6z
29. Hat84mlq6z
30. 1-piperazineethanol, 4-(3-(2-trifluoromethylthioxanth-9-ylidene)propyl)-, Dihydrochloride
31. 4-(3-(2-(trifluoromethyl)thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride
32. Cis-flupenthixol Hydrochloride
33. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride
34. Cis-flupenthixol Dihydrochloride
35. (z)-flupentixol Dihydrochloride
36. Schembl1153162
37. Chembl1496351
38. Ex-a352
39. Chebi:180489
40. Flupentixol Dihydrochloride (jan)
41. Cis-(z)-flupentixoldihydrochloride
42. Dtxsid501017247
43. Hms1569c21
44. Cis(z)-flupentixol Dihydrochloride
45. 4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Dihydrochloride
46. Cis-flupentixol Hydrochloride
47. Tox21_500528
48. Mfcd00069278
49. S3664
50. Akos025401529
51. Ac-2136
52. Ccg-221832
53. Lp00528
54. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)thioxanthen-9-ylidene)propyl)-, Dihydrochloride
55. Ncgc00093921-01
56. Ncgc00261213-01
57. .alpha.-flupenthixol Hydrochloride
58. 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)piperazine-1-ethanol Dihydrochloride
59. Bs-16961
60. Flupentixol Dihydrochloride, (z)-
61. Hy-15856
62. Thioxanthene, 9-(3-(4-(2-hydroxyethyl)piperazinyl)propylidene)-2-trifluoromethyl-, Dihydrochloride
63. B7578
64. Cs-0009393
65. Eu-0100528
66. F-114
67. D02236
68. 529f012
69. Sr-01000076232
70. J-015359
71. Sr-01000076232-1
72. Q27271910
73. Cis-(z)-flupenthixol Dihydrochloride, >=98% (hplc), Solid
74. (z)-2-(4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol Dihydrochloride
75. (z)-4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazine-ethanol Dihydrochloride
76. 1-(2-hydroxyethyl)-4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazinediium Dichloride
77. 1-piperazineethanol, 4-((3z)-3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride
78. 1-piperazineethanol, 4-(3-((3z)-2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Hydrochloride (1:2)
79. 2-(4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol--hydrogen Chloride (1/2)
80. 2-(4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethanol Dihydrochloride
81. 4-[3-[(3z)-2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Hydrochloride
| Molecular Weight | 507.4 g/mol |
|---|---|
| Molecular Formula | C23H27Cl2F3N2OS |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 506.1173245 g/mol |
| Monoisotopic Mass | 506.1173245 g/mol |
| Topological Polar Surface Area | 52 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 592 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
Flupentixol Dihydrochloride BP/EP
Date of Issue : 2025-08-19
Valid Till : 2028-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, 76/1 & 74, Chikhloli MIDC, Ambernath (West), Thane- 421501, Maha...
Flupentixol Dihydrochloride Ph.Eur.
Date of Issue : 2025-07-22
Valid Till : 2028-07-07
Written Confirmation Number : WC-0104
Address of the Firm : 124, 125 and 126, SIPCOT Industrial Complex, Hosur -635126, Tamil Nadu, India
Date of Issue : 2025-07-22
Valid Till : 2028-07-07
Written Confirmation Number : WC-0104
Address of the Firm : 124, 125 and 126, SIPCOT Industrial Complex, Hosur -635126, Tamil Nadu, India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : Chengdu Yazhong Bio-pharmaceutical Co., Ltd., founded in 2002, is a leading company with plant extracts, APIs and medical intermediates. Our company is equipped with GMP approved m...
About the Company : As an EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979 as Calcium Ind...
About the Company : Guangzhou Green Cross Pharmaceutical is a leading Chinese manufacturer of amino acid injection formulations and a full-service provider of high-end parenteral nutrition and generic...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, antidepressants and mus...
About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
2-Trifluoromethyl Thioxanthone
CAS Number : 1693-28-3
End Use API : Flupentixol Dihydrochloride
About The Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, ant...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 07-09-2021
Application Number : 28106552120
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 0.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Authorized
Registration Country : Spain
Flupentixol Dihydrochloride; Melitracene Hydrochloride
Brand Name : Deanxit Film-Coated Tablets
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 01-05-1972
Application Number : 50102
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol Mite
Dosage Form : Film Coated Tablet
Dosage Strength : 0.50mg
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769610
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769810
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol Mite
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769710
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : PRESCRIPTION
Registration Country : Canada
FLUPENTIXOL (FLUPENTIXOL DIHYDROCHLORIDE)
Brand Name : FLUANXOL 0.5MG - TAB
Dosage Form : TABLET
Dosage Strength : 0.5MG
Packaging : 100
Approval Date :
Application Number : 2156008
Regulatory Info : PRESCRIPTION
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 07-09-2021
Application Number : 28106552120
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 0.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Authorized
Registration Country : Spain
Flupentixol Dihydrochloride; Melitracene Hydrochloride
Brand Name : Deanxit Film-Coated Tablets
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 01-05-1972
Application Number : 50102
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol Mite
Dosage Form : Film Coated Tablet
Dosage Strength : 0.50mg
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769610
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769810
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fluanxol Mite
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 14-06-2012
Application Number : 28104769710
Regulatory Info : Prescription
Registration Country : Denmark
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
31 Aug 2022
Reply
07 Apr 2022
Reply
16 Oct 2020
Reply
15 Oct 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Flupentixol Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flupentixol Dihydrochloride manufacturer or Flupentixol Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flupentixol Dihydrochloride manufacturer or Flupentixol Dihydrochloride supplier.
A Flupentixol Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flupentixol Dihydrochloride, including repackagers and relabelers. The FDA regulates Flupentixol Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flupentixol Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flupentixol Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Flupentixol Dihydrochloride supplier is an individual or a company that provides Flupentixol Dihydrochloride active pharmaceutical ingredient (API) or Flupentixol Dihydrochloride finished formulations upon request. The Flupentixol Dihydrochloride suppliers may include Flupentixol Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Flupentixol Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Flupentixol Dihydrochloride written confirmation (Flupentixol Dihydrochloride WC) is an official document issued by a regulatory agency to a Flupentixol Dihydrochloride manufacturer, verifying that the manufacturing facility of a Flupentixol Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flupentixol Dihydrochloride APIs or Flupentixol Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Flupentixol Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Flupentixol Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Flupentixol Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flupentixol Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flupentixol Dihydrochloride GMP manufacturer or Flupentixol Dihydrochloride GMP API supplier for your needs.
A Flupentixol Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Flupentixol Dihydrochloride's compliance with Flupentixol Dihydrochloride specifications and serves as a tool for batch-level quality control.
Flupentixol Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Flupentixol Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flupentixol Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Flupentixol Dihydrochloride EP), Flupentixol Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flupentixol Dihydrochloride USP).
Comment (5)
